Treatment of chronic inflammatory disease is shifting from symptom management to a new frontier: Deep Healing. Beyond simply controlling inflammation, the goal is now to restore tissue structure, barrier integrity, and homeostatic set points to support truly durable outcomes.
J&J invites you to discuss the next paradigm shift in immunology. We will explore emerging biology—such as the restoration of epithelial barriers and modulation of neuro-immune signaling—needed to promote sustained remission in gut, skin, lung, and rheumatic conditions. Join us to explore how we can collaborate across the European life sciences ecosystem.